Icofungipen is a cyclic beta-amino acid being development by PLIVA, under license from Bayer, for the potential oral treatment of fungal infection. As of September 2002, the first phase II efficacy study was underway.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
icofungipen pliva
4
pliva icofungipen
4
icofungipen cyclic
4
cyclic beta-amino
4
beta-amino acid
4
acid development
4
development pliva
4
pliva license
4
license bayer
4
bayer potential
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!